Cancer

Title Average Ratingsort ascending
Low Dose naltrexone 100.00%
A phase II, single arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with unresectable metastatic colorectal carcinoma. 100.00%
A phase II, single arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with metastatic bladder cancer. 100.00%
CLINICAL EXPERIENCE OF CANCER IMMUNOTHERAPY INTEGRATED WITH OLEIC ACID COMPLEXED WITH DE-GLYCOSYLATED VITAMIN D BINDING PROTEIN 100.00%
A phase II, single-arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with advanced non-s 100.00%
63 year old woman with stage III malignant melanoma 100.00%
A prospective observational clinical study involving an alternative cancer treatment, psorinum therapy, in treating stomach, gal 100.00%
Improvement of the recurrence-free interval using biological adjuvant therapy in uveal melanoma. 100.00%
Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. 100.00%
Reversal of Signs and Symptoms of a B-Cell Lymphoma in a Patient Using Only Low-Dose Naltrexone 100.00%
Active specific immunotherapy with supportive measures in the treatment of palliatively nephrectomized, renal adenocarcinoma pat 100.00%
Psychodynamic psychotherapy, therapeutic touch and cancer. A review of the method of intervention and studv of 75 cases 100.00%
Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine. 100.00%
A phase II, single arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with unresectable m 100.00%
Oleic Acid, deglycosylated vitamin D-binding protein, nitric oxide: a molecular triad made lethal to cancer. 100.00%
3-Bromopyruvate (3BP) a fast acting, promising, powerful, specific, and effective "small molecule" anti-cancer agent taken from labside to bedside: introduction to a special issue. 100.00%
75 year old man, Prostate Cancer with bone and liver metastasis 100.00%
Improvement of dendritic cell therapy in glioblastoma multiforme WHO 4 by Newcastle disease virus. 100.00%
Psorinum therapy in treating stomach, gall bladder, pancreatic, and liver cancers: a prospective clinical study. 100.00%
Why is not Ukrain approved yet in Austria/EU? 98.57%
Bio-Immune therapy according to Professor Thomas Tallberg, a cure for Melanoma? 96.67%
Reducing malignant ascites accumulation by repeated intraperitoneal administrations of a Viscum album extract. 95.00%
Low-dose naltrexone for disease prevention and quality of life. 95.00%
Phase II study of docetaxel-prednisone (DP) in combination with metronomic cyclophosphamide (CTX) and celecoxib (C) ...... 95.00%
Herbo-mineral ayurvedic treatment in a high risk acute promyelocytic leukemia patient with second relapse: 12 years follow up. 95.00%
Ukrain (NSC-631570) in the treatment of pancreas cancer. 95.00%
DCA 95.00%
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer. 95.00%
Psorinum, the anti cancer miracle from India. 92.73%
Albarin, Injectable Aloe Vera or Polymannons 92.50%
Retrospective study of Ukrain treatment in 203 patients with advanced-stage tumors 90.00%
Chemotherapy of advanced epithelial cancer--a critical review 90.00%
MR-guided laser-induced interstitial thermotherapy of recurrent glioblastoma multiforme: preliminary results in 16 patients. 90.00%
Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer. 90.00%
Cellular immune suppression in cancer patients and its implication for dendritic cell therapy. 90.00%
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia. 90.00%
Mistletoe therapy in oncology 90.00%
Update on pilot study on antitumor efficacy of intravenously applied synergistic combinations of diflunisal, PAS, and aspirin in patients with advanced solid tumors. 90.00%
Metronomic chemotherapy: changing the paradigm that more is better. 90.00%
A translational study "case report" on the small molecule "energy blocker" 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedside. 90.00%
Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized ........ 90.00%
Hyperthermia and radiation therapy for locally advanced or recurrent breast cancer. 90.00%
Valproic acid: an old drug newly discovered as inhibitor of histone deacetylases. 90.00%
Effects of a high molecular mass Convolvulus arvensis extract on tumor growth and angiogenesis. 90.00%
Current perspectives on the medicinal potentials of Vernonia amygdalina Del. 90.00%
61 year old woman, Breast cancer with lymph, and lung metastasis 90.00%
A homeopathic approach to treat patients with advanced gallbladder, periampullary, and liver carcinomas: a report of 3 cases. 90.00%
Mycoplasma infections and different human carcinomas. 90.00%
Electromagnetic energy as a bridge between atomic and cellular levels in the genetics approach to cancer treatment. 90.00%
Improving conventional or low dose metronomic chemotherapy with targeted antiangiogenic drugs. 90.00%
The PEP-C regimen for recurring/refractory lymphoma: low-dose metronomic, multidrug therapy. 90.00%
Randomized Trials of Selenium, Vitamin E, or Vitamin C for Prostate Cancer Prevention 90.00%
A randomized trial of personalized peptide vaccine (PPV) plus low-dose estramustine (EMP) versus full-dose EMP in patients ..... 90.00%
Immunomodulatory effects of opioids. 90.00%
RECURRENCE OF BRAIN TUMORS MAY BE PREVENTED WITH RUTA AND CALCAREA PHOSPHORICA 90.00%
Chemical analyses of Ukrain, a semi-synthetic Chelidonium majus alkaloid derivative, fail to confirm its trimeric structure 90.00%
Adjuvant stereotactic body radiotherapy for resected pancreatic adenocarcinoma with close or positive margins. 90.00%
71 year old woman, Pancraetic cancer with liver and lung metastasis. 90.00%
Efficacy of homeopathic therapy in cancer treatment 90.00%
Mycoplasmas and oncogenesis: persistent infection and multistage malignant transformation. 90.00%
Opioid growth factor and the treatment of human pancreatic cancer: a review. 90.00%
Amplitude-modulated electromagnetic fields for the treatment of cancer: discovery of tumor-specific frequencies and assessment of a novel therapeutic approach. 90.00%
Vitamin D binding protein-macrophage activating factor directly inhibits proliferation, migration, and uPAR expression of prosta 90.00%
WHO’S AFRAID OF A CURE FOR CANCER? - The struggle for an alternative cancer drug 90.00%
Sanguinarine-induced apoptosis in human leukemia U937 cells via Bcl-2 downregulation and caspase-3 activation. 90.00%
Albumin Concentration Controls Cancer 90.00%
Current impediments to acceptance of the ultraviolet-B-vitamin D-cancer hypothesis. 90.00%
Role of infectious agents in the emergence of malignant tumors 90.00%
The long-term survival of a patient with pancreatic cancer with metastases to the liver after treatment with the intravenous alp 90.00%
Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors. 90.00%
Cellular immune suppression in cancer patients and its implication for dendritic cell therapy. Sub-category: Cell-Based Therapy 90.00%
Hyperthermia adds to chemotherapy. 90.00%
Metabolic modulation of glioblastoma with dichloroacetate. 90.00%
Clinical Investigations on Ukrain 90.00%
Open Source Cancer Resaearch - A video 90.00%
Adaptive therapy. 90.00%
71 year old woman. Breast cancer with bone metastasis 90.00%
Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor acti 90.00%
Systemic delivery of microencapsulated 3-bromopyruvate for the therapy of pancreatic cancer. 90.00%
Dendritic cell-based vaccination in combination with gemcitabine/S-1 in patients with advanced pancreatic cancer. Sub-category: 90.00%
Total pineal endocrine substitution therapy (TPEST) as a new neuroendocrine palliative treatment of untreatable metastatic soli 90.00%
Pre-Clinical Investigations on Ukrain 90.00%
Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic ca 90.00%
Cystatin C in LS lymphosarcoma and HA-1 hepatoma treated with Ukrain and cyclophosphamide and involvement of apoptosis. 90.00%
Vitamin D for cancer prevention: global perspective. 90.00%
NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell 90.00%
Case Report: A Breast Cancer Patient Treated with GcMAF, Sonodynamic Therapy and Hormone Therapy 90.00%
Artesunate in the treatment of metastatic uveal melanoma--first experiences. 90.00%
Prospective controlled cohort studies on long-term therapy of cervical cancer patients with a mistletoe preparation (Iscador). 90.00%
Combining agents that target the tumor microenvironment improves the efficacy of anticancer therapy. 90.00%
Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin. 90.00%
20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and 90.00%
Treatment of advanced pancreatic cancer with opioid growth factor: phase I. 90.00%
Cyclophosphamide plus somatostatin, bromocriptin, retinoids, melatonin and ACTH in the treatment of low-grade non-Hodgkin's .... 90.00%
In-vitro toxicity of Ukrain against human Ewing tumor cell lines. 90.00%
A phase II, single-arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with advanced esoph 90.00%
Debate in Lancet about setting up a phase II trial on Ukrain in England 90.00%
42 year old man. Kidney cancer 90.00%
Artemisinin derivates in the treatment of Cancer 90.00%
Dichloroacetic acid 90.00%

Pages